ATE134880T1 - Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen - Google Patents

Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen

Info

Publication number
ATE134880T1
ATE134880T1 AT89904944T AT89904944T ATE134880T1 AT E134880 T1 ATE134880 T1 AT E134880T1 AT 89904944 T AT89904944 T AT 89904944T AT 89904944 T AT89904944 T AT 89904944T AT E134880 T1 ATE134880 T1 AT E134880T1
Authority
AT
Austria
Prior art keywords
immune complexes
binding
modified forms
contacting
reactive protein
Prior art date
Application number
AT89904944T
Other languages
English (en)
Inventor
Lawrence A Potempa
Byron E Anderson
Original Assignee
Lawrence A Potempa
Byron E Anderson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lawrence A Potempa, Byron E Anderson filed Critical Lawrence A Potempa
Application granted granted Critical
Publication of ATE134880T1 publication Critical patent/ATE134880T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
AT89904944T 1988-04-04 1989-03-31 Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen ATE134880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17692388A 1988-04-04 1988-04-04

Publications (1)

Publication Number Publication Date
ATE134880T1 true ATE134880T1 (de) 1996-03-15

Family

ID=22646454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904944T ATE134880T1 (de) 1988-04-04 1989-03-31 Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen

Country Status (6)

Country Link
EP (1) EP0411017B1 (de)
AT (1) ATE134880T1 (de)
AU (1) AU633488B2 (de)
CA (1) CA1339290C (de)
DE (1) DE68925899T2 (de)
WO (1) WO1989009628A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015515C (en) * 1990-01-03 1999-12-07 Jean-Marie Saint-Remy Pharmaceutical compositions containing antigen-antibody complexes and uses therefor
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5221628A (en) * 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
US5874238A (en) * 1993-02-26 1999-02-23 Immtech International Inc. Mutant protein and methods and materials for making and using it
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
DE69230643T2 (de) * 1991-11-27 2000-06-21 Immtech International Inc., Evanston Methode zur behandlung von viralen infektionen
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
US6703219B1 (en) 1993-02-26 2004-03-09 Immtech International Inc. Mutant protein and methods and materials for making and using it
AU6252294A (en) * 1993-02-26 1994-09-14 Immtech International, Inc. A mutant protein and methods and materials for making and using it
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
AU774889B2 (en) 1999-02-04 2004-07-08 Biomerieux, Inc. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6251624B1 (en) 1999-03-12 2001-06-26 Akzo Nobel N.V. Apparatus and method for detecting, quantifying and characterizing microorganisms
CN1434726A (zh) 2000-06-08 2003-08-06 拉卓拉药物公司 包含高分子量聚环氧乙烷的多价平台分子
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
DE10117043A1 (de) * 2001-04-05 2002-11-07 Gerhard Puetz Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen
US6872541B2 (en) * 2001-07-25 2005-03-29 Coulter International Corp. Method and compositions for analysis of pentraxin receptors as indicators of disease
DE10226011A1 (de) * 2002-06-12 2004-01-08 Aventis Pharma Deutschland Gmbh HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
CN105388292A (zh) * 2015-10-19 2016-03-09 清华大学深圳研究生院 试剂盒及联合检测pct、crp及il-6的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617262A (en) * 1983-07-22 1986-10-14 Cooperbiomedical, Inc. Assaying for circulating immune complexes with labeled protein A
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
US4801449A (en) * 1985-01-11 1989-01-31 Imre Corporation Method for treatment of Kaposi's sarcoma

Also Published As

Publication number Publication date
EP0411017A1 (de) 1991-02-06
CA1339290C (en) 1997-08-12
EP0411017A4 (en) 1991-11-21
DE68925899T2 (de) 1996-10-02
AU633488B2 (en) 1993-02-04
WO1989009628A1 (en) 1989-10-19
EP0411017B1 (de) 1996-03-06
DE68925899D1 (de) 1996-04-11
AU3448589A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
ATE134880T1 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
ATE182625T1 (de) Rekombinante anti-vla4 antikörpermoleküle
ATE98776T1 (de) Monoklonale antikoerper fuer hba1c.
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
NO821431L (no) Fremgangsmaate og sett for proeving av antilegemer mot antigener
ATE123072T1 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
ATE121788T1 (de) Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.
DE69200460D1 (de) Agglutinationskomplex zum Nachweis von Blutgruppen.
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
ATE105086T1 (de) Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b.
GB2233091A (en) Immunoassays using monoclonal antibodies directed against natural binding proteins
DE3684223D1 (de) Monoklonale antikoerper.
FI882019L (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
DK608789D0 (da) Cea-immunanalyse uden falske positive foraarsaget af humant anti-museantistof
NO972046L (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
EP0721958A3 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
Podhradska et al. Effect of inflammation on serum glycoproteins in rabbits
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
ATE64466T1 (de) Immuntest.
SE9700745D0 (sv) Improved immunoassays and improved diagnostic methods and a kit to be used in the methods